J B Chemicals & Pharmaceuticals Share Price

  • 1,668.50-33.60 (-1.98%)
  • Volume: 1,90,360
  • Live
  • Last Updated On: 21 May, 2025, 02:03 PM IST
Loading...
J B Chemicals & Pharmaceuticals Share Price
  • 1,668.50-33.60 (-1.98%)
  • Volume: 1,90,360
Advertisment
Stock Recommendations
  • Potential
    Upside

  • 1 Year
    Target

STRONG BUY

Mean Recos by
12 Analysts

0

0

1

4

7

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

J B Chemicals share price insights

  • Company has spent less than 1% of its operating revenues towards interest expenses and 17.55% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • J B Chemicals & Pharmaceuticals Ltd. share price moved down by -2.00% from its previous close of Rs 1,702.10. J B Chemicals & Pharmaceuticals Ltd. stock last traded price is 1,668.20

    Share PriceValue
    Today/Current/Last1,668.20
    Previous Day1,702.101,703.80

InsightsJ B Chemicals

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    39.39
    EPS - TTM
    (₹)
    42.37
    MCap
    (₹ Cr.)
    26,044.80
    Sectoral MCap Rank
    20
    PB Ratio
    (x)
    7.72
    Div Yield
    (%)
    0.93
    Face Value
    (₹)
    1.00
    Beta

    Beta

    1 Month0.17
    3 Months0.06
    6 Months0.42
    1 Year0.52
    3 Years0.69
    0.17
    VWAP
    (₹)
    1,678.66
    52W H/L
    (₹)
    2,030.00 / 1,385.75

    J B Chemicals Share Price Returns

    1 Day-1.98%
    1 Week3.46%
    1 Month0.59%
    3 Months3.84%
    1 Year-5.93%
    3 Years109.8%
    5 Years398.47%

    ET Stock ScreenersTop Score Companies

    Check whether J B Chemicals belongs to analysts' top-rated companies list?

    View Stock Screeners

    J B Chemicals Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 12 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹2225
    • OrganizationJM Financial
    • BUY
    • Target₹1815
    • OrganizationICICI Securities
    • ADD

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy7777
    Buy4222
    Hold1111
    Sell-111
    Strong Sell----
    # Analysts12111111

    J B Chemicals Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 17.55% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income963.96971.491,010.571,010.29878.36
      Total Income Growth (%)-0.78-3.870.0315.023.11
      Total Expenses769.48750.92771.98764.81704.35
      Total Expenses Growth (%)2.47-2.730.948.587.47
      EBIT194.48220.57238.59245.48174.01
      EBIT Growth (%)-11.83-7.55-2.8141.07-11.42
      Profit after Tax (PAT)145.69162.49174.57176.83126.16
      PAT Growth (%)-10.34-6.92-1.2840.16-5.55
      EBIT Margin (%)20.1822.7023.6124.3019.81
      Net Profit Margin (%)15.1116.7317.2717.5014.36
      Basic EPS (₹)9.3610.4611.2411.398.22
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income914.87920.67964.65957.47825.30
      Total Income Growth (%)-0.63-4.560.7516.012.30
      Total Expenses714.77709.29728.43718.94653.87
      Total Expenses Growth (%)0.77-2.631.329.955.67
      EBIT200.10211.38236.22238.53171.43
      EBIT Growth (%)-5.34-10.52-0.9739.14-8.78
      Profit after Tax (PAT)149.80156.39173.12173.23125.85
      PAT Growth (%)-4.21-9.66-0.0637.65-1.62
      EBIT Margin (%)21.8722.9624.4924.9120.77
      Net Profit Margin (%)16.3716.9917.9518.0915.25
      Basic EPS (₹)9.6310.0611.1511.168.11
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue3,956.313,521.453,159.222,463.472,154.90
      Total Revenue Growth (%)12.3511.4728.2414.3218.05
      Total Expenses3,068.922,769.942,603.991,958.571,558.02
      Total Expenses Growth (%)10.796.3732.9525.716.24
      Profit after Tax (PAT)659.58552.63409.84385.36447.96
      PAT Growth (%)19.3534.846.35-13.9864.66
      Operating Profit Margin (%)22.9422.8418.7721.0329.57
      Net Profit Margin (%)16.8315.8613.0115.8921.93
      Basic EPS (₹)42.4535.6653.0049.8657.96
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue3,757.663,333.322,892.812,228.492,003.88
      Total Revenue Growth (%)12.7315.2329.8111.2118.57
      Total Expenses2,880.552,594.982,365.771,757.201,410.18
      Total Expenses Growth (%)11.009.6934.6324.615.20
      Profit after Tax (PAT)652.54543.36388.89361.00447.08
      PAT Growth (%)20.0939.727.72-19.2566.73
      Operating Profit Margin (%)23.8023.6119.4621.7431.76
      Net Profit Margin (%)17.5216.4713.4816.4823.63
      Basic EPS (₹)42.0035.0750.2946.7157.85

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,273.783,994.133,553.872,607.402,238.12
      Total Assets Growth (%)7.0012.3936.3016.5023.41
      Total Liabilities840.461,070.801,073.52468.79424.69
      Total Liabilities Growth (%)-21.51-0.25129.0010.3913.08
      Total Equity3,433.322,923.332,480.352,138.611,813.43
      Total Equity Growth (%)17.4517.8615.9817.9326.11
      Current Ratio (x)3.062.132.763.324.50
      Total Debt to Equity (x)0.000.120.220.010.02
      Contingent Liabilities0.001,110.90148.8668.13121.03
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets4,177.903,913.643,470.152,538.072,200.43
      Total Assets Growth (%)6.7512.7836.7215.3421.50
      Total Liabilities800.701,027.381,027.67434.40393.97
      Total Liabilities Growth (%)-22.06-0.03136.5710.267.72
      Total Equity3,377.202,886.262,442.482,103.671,806.46
      Total Equity Growth (%)17.0118.1716.1116.4524.99
      Current Ratio (x)3.062.092.753.324.74
      Total Debt to Equity (x)0.000.120.220.010.01
      Contingent Liabilities0.001,110.90148.8668.13117.00

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 295.89 cr for investing activities which is an YoY decrease of 26.73%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities902.45800.61625.61170.13314.78
      Net Cash used in Investing Activities-295.89-403.83-961.792.32-230.68
      Net Cash flow from Financing Activities-579.68-385.49356.54-138.39-87.42
      Net Cash Flow26.8711.2820.3934.07-3.28
      Closing Cash & Cash Equivalent115.0988.2276.9356.5422.47
      Closing Cash & Cash Equivalent Growth (%)30.4714.6636.06151.60-12.73
      Total Debt/ CFO (x)0.020.450.880.150.10
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities884.04789.03628.64147.10335.43
      Net Cash used in Investing Activities-289.93-412.45-955.884.18-230.68
      Net Cash flow from Financing Activities-574.26-374.08343.41-137.85-86.90
      Net Cash Flow19.842.4916.2013.4217.90
      Closing Cash & Cash Equivalent76.2156.3753.8837.6924.26
      Closing Cash & Cash Equivalent Growth (%)35.194.6242.9855.33281.09
      Total Debt/ CFO (x)0.000.430.840.180.08

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)19.2118.9016.5218.0524.75
      Return on Capital Employed (%)24.6925.4519.7122.9331.91
      Return on Assets (%)15.4313.8311.5314.7720.01
      Interest Coverage Ratio (x)91.2321.0719.57113.7983.43
      Asset Turnover Ratio (x)0.950.921.020.9291.26
      Price to Earnings (x)38.3146.5137.3131.6521.65
      Price to Book (x)7.368.766.155.705.35
      EV/EBITDA (x)23.4927.6822.2820.8414.41
      EBITDA Margin (%)27.3126.8122.4024.0332.93
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)19.3218.8215.9217.1624.74
      Return on Capital Employed (%)24.6625.1818.9521.7331.74
      Return on Assets (%)15.6113.8811.2014.2220.31
      Interest Coverage Ratio (x)115.4322.5619.63110.6483.55
      Asset Turnover Ratio (x)0.920.890.960.9285.98
      Price to Earnings (x)38.7647.1739.2233.7821.69
      Price to Book (x)7.488.876.245.795.36
      EV/EBITDA (x)23.9128.3123.3522.2114.50
      EBITDA Margin (%)28.2727.7123.3425.0035.32

    Financial InsightsJ B Chemicals

    • Income (P&L)
    • Cash Flow
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 17.55% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 295.89 cr for investing activities which is an YoY decrease of 26.73%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    J B Chemicals Share Price Forecast

    • Get multiple analysts’ prediction on J B Chemicals

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on J B Chemicals

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on J B Chemicals

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    J B Chemicals Technicals

    • Bullish / Bearish signals for J B Chemicals basis selected technical indicators and moving average crossovers.

      200 Day EMA Crossover

      Bullish signal on daily chart

      Appeared on:

    J B Chemicals Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      J B Chemicals39.497.5919.2124.6915.4316.9222.9416.8342.453.060.000.02
      Ajanta Pharma35.758.6824.2830.1018.3511.0026.0219.8073.562.850.000.00
      Piramal Pharma299.863.361.126.400.5810.648.340.190.691.540.585.29
      Suven Pharma 97.0813.2214.6419.2413.322.8039.2928.5611.8011.820.020.11
      Gland Pharma36.882.958.8512.507.2417.3020.4513.6346.904.040.040.32
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Syngene Int.
      • Wockhardt
      • Emcure Pharmaceuticals Ltd.
      • Eris Lifesciences
      • Concord Biotech Ltd.

      Choose from Stocks

      Peers InsightsJ B Chemicals

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        J B Chemicals Shareholding Pattern

        • Loading...
          Showing J B Chemicals Shareholding as on Mar 2025
          CategoryMar 2025Dec 2024Sep 2024Jun 2024
          Promoters47.8453.6653.7453.77
          Pledge0.000.000.000.00
          FII18.3014.6413.6212.17
          DII18.7116.4016.8017.61
          Mutual Funds16.2614.5714.6015.04
          Others15.1515.3015.8416.45
        • Showing Shareholding as on Mar 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters7,44,81,51947.84 %-5.81
          Pledge00.00 %0.00
          FII2,84,85,74218.30 %3.66
          DII2,91,33,40418.71 %2.31
          MF2,53,20,57116.26 %1.69
          Others2,35,76,54315.15 %-0.15

        J B Chemicals MF Ownership

        MF Ownership as on 30 April 2025

        J B Chemicals Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          May 14, 2025Apr 22, 2025Board MeetingAudited Results & Final Dividend
          Feb 04, 2025Jan 24, 2025Board MeetingQuarterly Results & Interim Dividend
          Nov 06, 2024Oct 25, 2024Board MeetingQuarterly Results
          Aug 21, 2024Jul 26, 2024AGM-
          Aug 08, 2024Jul 26, 2024Board MeetingQuarterly Results
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Interim850%8.5Feb 07, 2025Feb 05, 2025
          Final675%6.75Aug 14, 2024May 17, 2024
          Interim550%5.5Feb 16, 2024Feb 06, 2024
          Final462%9.25Aug 17, 2023May 29, 2023
          Final700%7.0-May 14, 2025
        • All TypesEx-DateRecord DateAnnounced onDetails
          SplitsSep 18, 2023Sep 18, 2023May 24, 2023Split: Old FV2.0| New FV:1.0
          SplitsApr 05, 2005Apr 12, 2005Jan 27, 2005Split: Old FV10.0| New FV:2.0
          BonusOct 05, 1998Oct 30, 1998Aug 29, 1998Bonus Ratio: 1 share(s) for every 1 shares held
          RightsJun 10, 1996-Dec 07, 1996Rights ratio: 1 share for every 5 held at a price of Rs 80.0
          BonusOct 01, 1993Oct 25, 1993Sep 30, 1993Bonus Ratio: 1 share(s) for every 2 shares held

        About J B Chemicals

        J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 26,497.82 Crore) operating in Pharmaceuticals sector. J B Chemicals & Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services and Scrap for the year ending 31-Mar-2023. Show More

        • Executives

        • Auditors

        • AD

          Arun Duggal

          Chairman & Ind.Director
          NC

          Nikhil Chopra

          WholeTime Director & CEO
          AT

          Akshay Tanna

          Non Executive Director
          GT

          Gaurav Trehan

          Non Executive Director
          Show More
        • Deloitte Haskins & Sells LLP
          D N V & Co.

        FAQs about J B Chemicals share

        • 1. What is J B Chemicals share price and what are the returns for J B Chemicals share?
          J B Chemicals share price is Rs 1,668.20 as on 21 May, 2025, 02:03 PM IST. J B Chemicals share price is down by 2.00% based on previous share price of Rs 1,663.9. J B Chemicals share price trend:
          • Last 3 Months: J B Chemicals share price moved up by 3.82%
          • Last 3 Years: J B Chemicals Share price moved up by 109.76%
        • 2. What are the key metrics to analyse J B Chemicals Share Price?
          Key Metrics for J B Chemicals are:
          • PE Ratio of J B Chemicals is 39.39
          • Price/Sales ratio of J B Chemicals is 6.45
          • Price to Book ratio of J B Chemicals is 7.72
        • 3. What are the J B Chemicals quarterly results?
          On Consoldiated basis, J B Chemicals reported a total income and loss of Rs 963.96 Cr and Rs 145.69 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2025-03-31 was Rs 3956.31 Cr and Rs 659.58 Cr.
        • 4. Who's the owner of J B Chemicals?
            • Promoter holding have gone down from 53.77 (30 Jun 2024) to 47.84 (31 Mar 2025)
            • Domestic Institutional Investors holding has gone up from 17.61 (30 Jun 2024) to 18.71 (31 Mar 2025)
            • Foreign Institutional Investors holding has gone up from 12.17 (30 Jun 2024) to 18.3 (31 Mar 2025)
            • Other investor holding have gone down from 16.45 (30 Jun 2024) to 15.15 (31 Mar 2025)
        • 5. Which are the key peers to J B Chemicals?
          Within Pharmaceuticals sector J B Chemicals, Wockhardt Ltd., Gland Pharma Ltd., Concord Biotech Ltd., Emcure Pharmaceuticals Ltd., Natco Pharma Ltd., Cohance Lifesciences Ltd., Syngene International Ltd., Piramal Pharma Ltd., Eris Lifesciences Ltd. and Ajanta Pharma Ltd. are usually compared together by investors for analysis.
        • 6. What dividend is J B Chemicals giving?
          J B Chemicals & Pharmaceuticals Ltd. announced an equity dividend of 850% on a face value of 1.0 amounting to Rs 8.5 per share on 05 Feb 2025. The ex dividend date was 07 Feb 2025.
        • 7. What has been highest price of J B Chemicals share in last 52 weeks?
          52 Week high of J B Chemicals share is Rs 2,030.00 while 52 week low is Rs 1,385.75
        • 8. What are the returns for J B Chemicals share?
          Return Performance of J B Chemicals Shares:
          • 1 Week: J B Chemicals share price moved up by 3.44%
          • 3 Month: J B Chemicals share price moved up by 3.82%
        • 9. What is the market cap of J B Chemicals?
          Within the Pharmaceuticals sector, J B Chemicals stock has a market cap rank of 20. J B Chemicals has a market cap of Rs 26,044.80 Cr.
        • 10. What is the PE & PB ratio of J B Chemicals?
          The PE ratio of J B Chemicals stands at 40.17, while the PB ratio is 7.72.
        • 11. What is the CAGR of J B Chemicals?
          The CAGR of J B Chemicals is 12.75.
        • 12. Who's the chairman of J B Chemicals?
          Arun Duggal is the Chairman & Ind.Director of J B Chemicals
        • 13. Who is the CEO of J B Chemicals?
          Nikhil Chopra is the WholeTime Director & CEO of J B Chemicals

        Trending in Markets

        Top Gainers As on 02:01 PM | 21 May 2025

        JK Tyre387.05
        39.16 (11.26%)
        Tata Teleservices62.82
        4.60 (7.89%)
        Go Digit General Ins325.80
        21.75 (7.16%)
        Caplin Point2,255.80
        128.81 (6.06%)
        Solar Ind.14,275.00
        786.00 (5.83%)

        Top Losers As on 02:00 PM | 21 May 2025

        Dixon Tech15,565.00
        -1001.00 (-6.05%)
        Newgen Software1,268.70
        -65.85 (-4.94%)
        Aster DM Health551.80
        -27.61 (-4.77%)
        Radico Khaitan2,452.00
        -108.70 (-4.25%)
        Signatureglobal India1,206.00
        -52.30 (-4.16%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times